Katherine A Johnson

7PUBLICATIONS
50CO-AUTHORS
ChemotherapyPredictive and prognostic markersMolecular targetsCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 27, 2026
Organoid Level Assessments of Human Primary and Metastatic Colorectal Cancer-Derived Organoids Predict Response to Chemotherapy and Chemoradiation.

|Feb 11, 2026
Tumor Matrix Proteoglycan Accumulation and Processing Alter T-cell Effector Function and the Response to Immunotherapy in Patients with Oligometastatic Colorectal Cancer.

Dustin A Deming, Sean G Kraus, Joshua Brand

|Nov 27, 2025
Correction: Schmitz et al. The Precision-Guided Use of PI3K Pathway Inhibitors for the Treatment of Solid Malignancies. Biomedicines 2025, 13, 1319.

Alexa E Schmitz, Shirsa Udgata, Katherine A Johnson

|Jul 10, 2025
BCL-2 Family Inhibition Enhances mTORC1/2 Inhibition in PIK3CA-Mutant Colorectal Cancer.

Rebecca A DeStefanis, Alexa E Schmitz, Alyssa K Steimle

|Jun 26, 2025
The Precision-Guided Use of PI3K Pathway Inhibitors for the Treatment of Solid Malignancies.

Alexa E Schmitz, Shirsa Udgata, Katherine A Johnson

|May 14, 2025
Stromal Versican Accumulation and Proteolysis Regulate the Infiltration of CD8+ T Cells in Breast Cancer.

Philip B Emmerich, Tonela Qyli, Katherine A Johnson

Pageof 2

Frequent Collaborators

4 joint publications

Cheri A Pasch

3 joint publications

Shirsa Udgata

2 joint publications

Jeremy Kratz

2 joint publications

Dustin A Deming